Cyclophosphamide

nuclear receptor subfamily 1, group I, member 3 ; Mus musculus







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33796409 Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine. 2021 Mar 18 2
2 27605551 Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells. 2016 Sep 7 4